Filing Details
- Accession Number:
- 0001209191-15-038051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-01 17:08:26
- Reporting Period:
- 2015-04-29
- Filing Date:
- 2015-05-01
- Accepted Time:
- 2015-05-01 17:08:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-29 | 1,300 | $17.16 | 387,584 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-04-29 | 10,400 | $35.64 | 397,984 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-29 | 4,300 | $123.72 | 393,684 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-29 | 4,700 | $124.64 | 388,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-29 | 2,000 | $125.63 | 386,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-29 | 700 | $126.66 | 386,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-04-29 | 1,300 | $0.00 | 1,300 | $17.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-04-29 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,800 | 2015-07-19 | No | 4 | M | Direct | |
| 406,400 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $123.72 (range $123.15 to $124.09).
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $124.64 (range $124.17 to $125.16).
- Open market sales reported on this line occurred at a weighted average price of $125.63 (range $125.21 to $126.17).
- Open market sales reported on this line occurred at a weighted average price of $126.66 (range $126.40 to $127.15).
- Common stock held in grantor retained annuity trusts.
- Fully vested.
Billionaire Hedge Funds
